RBREW Stock Analysis: Royal Unibrew | CO
Beverages - Brewers | CO, Denmark | Market Cap: 20.251m DKK | 12M Return: -10.6% | DK0060634707 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.7M
EPS Trend: 98.8%
Qual. Beats: 0
Rev. Trend: 92.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Royal Unibrew A/S is a Denmark-headquartered beverage producer operating across Northern, Western, and Southern Europe, with a portfolio spanning soft drinks, energy drinks, bottled water, malt beverages, beers, ready-to-drink cocktails and ciders, juices, enhanced beverages, and tea and coffee. The company markets a large multi-brand portfolio, including owned labels such as Faxe Kondi, Jaffa, Ceres, Lapin Kulta, Hartwall, and Looza, alongside numerous partner and licensed brands. Originally founded in 1901 and previously known as Bryggerigruppen A/S before adopting its current name in 2005, Royal Unibrew is classified within the Consumer Staples sector under the Brewers sub-industry.
Its business model is built on a multi-category, multi-brand approach that diversifies revenue beyond traditional brewing into non-alcoholic and functional beverages, reducing reliance on any single product type or geography. The companys footprint is concentrated in the Nordic and Baltic regions, with selected expansion into Western and Southern Europe, reflecting a regional roll-up strategy common among mid-cap European beverage consolidators.
- Nordic beer volume growth and pricing drive core revenue
- Aluminum and sugar input costs pressure gross margins
- Acquisitions and licensing expand Baltics, energy, and craft portfolio
| Net Income: 1.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.55 > 1.0 |
| NWC/Revenue: -13.70% < 20% (prev -13.32%; Δ -0.38% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.33b > Net Income 1.61b |
| Net Debt (6.61b) to EBITDA (2.86b): 2.31 < 3 |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.8m) vs 12m ago -2.36% < -2% |
| Gross Margin: 43.49% > 18% (prev 42.71%; Δ 0.78% > 0.5%) |
| Asset Turnover: 82.75% > 50% (prev 80.69%; Δ 2.06% > 0%) |
| Interest Coverage Ratio: 8.11 > 6 (EBIT TTM 2.09b / Interest Expense TTM 258.0m) |
| A: -0.11 (Total Current Assets 4.22b - Total Current Liabilities 6.39b) / Total Assets 19.3b |
| B: 0.24 (Retained Earnings 4.63b / Total Assets 19.3b) |
| C: 0.11 (EBIT TTM 2.09b / Avg Total Assets 19.1b) |
| D: 0.48 (Book Value of Equity 6.21b / Total Liabilities 13.1b) |
| Altman-Z'' = 1.28 = BB |
| DSRI: 0.99 (Receivables 2.46b/2.39b, Revenue 15.8b/15.3b) |
| GMI: 0.98 (GM 42.71% / 43.49%) |
| AQI: 0.99 (AQ_t 0.51 / AQ_t-1 0.51) |
| SGI: 1.03 (Revenue 15.8b / 15.3b) |
| TATA: -0.04 (NI 1.61b - CFO 2.33b) / TA 19.3b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of October 24, 2026, the stock is trading at DKK 433.80 with a total of 145,161 shares traded. Over the past week, the price has changed by +1.02%, over one month by +4.08%, over three months by -6.67% and over the past year by -10.61%.
Current recommended Stop Loss: 417.30 (which is 3.8% or 2.1 ATR below the current price).
Royal Unibrew has no consensus analysts rating.
P/E Trailing = 13.1315
P/E Forward = 11.1483
P/S = 1.2804
P/B = 3.1743
P/EG = 6.1963
Revenue TTM = 15.8b DKK
EBIT TTM = 2.09b DKK
EBITDA TTM = 2.86b DKK
Long Term Debt = 5.38b DKK (from longTermDebt, last quarter)
Short Term Debt = 1.28b DKK (from shortTermDebt, last quarter)
Debt = 6.66b DKK (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.61b DKK (calculated: Debt 6.66b - CCE 54.0m)
Enterprise Value = 26.9b DKK (20.3b + Debt 6.66b - CCE 54.0m)
Interest Coverage Ratio = 8.11 (Ebit TTM 2.09b / Interest Expense TTM 258.0m)
EV/FCF = 17.05x (Enterprise Value 26.9b / FCF TTM 1.57b)
FCF Yield = 5.86% (FCF TTM 1.57b / Enterprise Value 26.9b)
FCF Margin = 9.96% (FCF TTM 1.57b / Revenue TTM 15.8b)
Net Margin = 10.19% (Net Income TTM 1.61b / Revenue TTM 15.8b)
Gross Margin = 43.49% ((Revenue TTM 15.8b - Cost of Revenue TTM 8.94b) / Revenue TTM)
Gross Margin QoQ = 46.16% (prev 40.59%)
Tobins Q-Ratio = 1.39 (Enterprise Value 26.9b / Total Assets 19.3b)
Interest Expense / Debt = 3.87% (Interest Expense 258.0m / Debt 6.66b)
Taxrate = 20.64% (419.0m / 2.03b)
NOPAT = 1.66b (EBIT 2.09b * (1 - 20.64%))
Current Ratio = 0.66 (Total Current Assets 4.22b / Total Current Liabilities 6.39b)
Debt / Equity = 1.07 (Debt 6.66b / totalStockholderEquity, last quarter 6.21b)
Debt / EBITDA = 2.31 (Net Debt 6.61b / EBITDA 2.86b)
Debt / FCF = 4.20 (Net Debt 6.61b / FCF TTM 1.57b)
Total Stockholder Equity = 6.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.43% (Net Income 1.61b / Total Assets 19.3b)
RoE = 24.45% (Net Income TTM 1.61b / Total Stockholder Equity 6.59b)
RoCE = 17.48% (EBIT 2.09b / Capital Employed (Equity 6.59b + L.T.Debt 5.38b))
RoIC = 11.78% (NOPAT 1.66b / Invested Capital 14.1b)
WACC = 4.33% (E(20.3b)/V(26.9b) * Re(4.75%) + D(6.66b)/V(26.9b) * Rd(3.87%) * (1-Tc(0.21)))
Discount Rate = 4.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -70.77 | Cagr: -1.06%
[DCF] Terminal Value 77.97% ; FCFF base≈1.45b ; Y1≈1.66b ; Y5≈2.44b
[DCF] Fair Price = 639.0 (EV 36.7b - Net Debt 6.61b = Equity 30.1b / Shares 47.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.84 | EPS CAGR: 18.86% | SUE: -0.53 | # QB: 0
Revenue Correlation: 92.78 | Revenue CAGR: 8.99% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-09-30): EPS=12.22 | Chg30d=+0.00% | Revisions=+50% | Analysts=5
EPS current Year (2026-12-31): EPS=34.06 | Chg30d=-0.07% | Revisions=-57% | GrowthEPS=+8.8% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=37.67 | Chg30d=-0.03% | Revisions=-12% | GrowthEPS=+10.6% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -13% (up=5, down=7)